Science
CAR NKT cells offer a promising approach to combating difficult-to-treat solid… – AlKhaleej Today
CAR NKT cells offer a promising approach to combating difficult-to-treat solid…
Reviewed by Emily Henderson, B.Sc.October 13, 2020Natural killer T cells (NKT), a type of immune cell known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy for treating cancer patients.
Researchers at Baylor College of Medicine and the University of North Carolina at Chapel Hill have genetically engineered human NKT cells with a chimeric antigen receptor (CAR) that allows them to specifically recognize neuroblastoma, a form…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants